Journal of Clinical Endocrinology & Metabolism, Vol 74, 198-203, Copyright © 1992 by Endocrine Society

ARTICLES

Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency

AC Moreira and LL Elias
Department of Medicine, Faculty of Medicine, Ribeirao Preto, SP, Brazil.

21-Hydroxylase congenital adrenal hyperplasia (21-OHCAH) involves a primary defect of the adrenal gland and a secondary involvement of ACTH secretion. The responses of the pituitary-adrenal axis to ovine CRH (oCRH, 1 micrograms/kg) were examined in subjects with different degrees of 21-OH deficiency. We studied 43 subjects: 7 classical and 6 nonclassical (NC) 21-OHCAH patients, 15 heterozygotes (HT) and 15 control subjects. Baseline plasma ACTH levels were higher in classical CAH than in NC-CAH, HT, and control subjects (mean +/- SEM, 66 +/- 14, 6 +/- 1.6, 4 +/- 0.5, and 5 +/- 0.5 pmol/L, respectively). The mean plasma ACTH response to oCRH in NC-CAH (17 +/- 3 pmol/L) was higher than in controls and HT (9 +/- 0.8 and 11 +/- 1.5 pmol/L). The highest ACTH responses to oCRH were obtained for classical CAH patients (126 +/- 29 pmol/L). Plasma cortisol rose after oCRH in control, HT, and NC-CAH patients but did not change in classical CAH. After oCRH, plasma 17- hydroxyprogesterone (17-OHP) were 4 +/- 0.5, 8 +/- 1.6, 93 +/- 28, and 359 +/- 110 nmol/L for controls, HT, NC-CAH, and classical patients, respectively. There was a significant correlation (r = 0.70) between 17- OHP and the ACTH responses to oCRH. The 17-OHP responses to oCRH were also correlated (r = 0.94) with the 17-OHP responses to the synthetic ACTH test. We conclude that the release of endogenous ACTH by oCRH result in graded 17-OHP responses on 21-OH deficiency. The present study also suggests that different degrees of adrenal biosynthetic defect may result in graded ACTH responses to oCRH.

This article has been cited by other articles:

				F. C. Soardi, J. Y. Penachioni, G. Z. Justo, T. A. S. S. Bachega, M. Inacio, B. B. Mendonca, M. de Castro, and M. P. de Mello Novel Mutations in CYP11B1 Gene Leading to 11{beta}-Hydroxylase Deficiency in Brazilian Patients J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3481 - 3485. [Abstract] [Full Text] [PDF]

				K. Prank, E. Schulze, O. Eckert, T. W Nattkemper, M. Bettendorf, C. Maser-Gluth, T. J Sejnowski, A. Grote, E. Penner, A. von zur Muhlen, et al. Machine learning approaches for phenotype-genotype mapping: predicting heterozygous mutations in the CYP21B gene from steroid profiles Eur. J. Endocrinol., August 1, 2005; 153(2): 301 - 305. [Abstract] [Full Text] [PDF]

				L. M. Mermejo, L. L. K. Elias, S. Marui, A. C. Moreira, B. B. Mendonca, and M. de Castro Refining Hormonal Diagnosis of Type II 3{beta}-Hydroxysteroid Dehydrogenase Deficiency in Patients with Premature Pubarche and Hirsutism Based on HSD3B2 Genotyping J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1287 - 1293. [Abstract] [Full Text] [PDF]

				R. Azziz and S. M. Slayden The 21-Hydroxylase-Deficient Adrenal Hyperplasias: More Than ACTH Oversecretion Reproductive Sciences, November 1, 1996; 3(6): 297 - 302. [Abstract] [PDF]